Bone status in preterm infant: influences of different nutritional regimens and possible markers of bone disease

M Meneghelli1, A Pasinato1, S Salvadori1

  • 1Neonatal Intensive Care Unit, Women's and Children's Health Department, University Hospital of Padova, Padova, Italy.

Insights

Aggressive parenteral nutrition in preterm infants promotes better growth and bone development. Early nutritional support is crucial for improving bone status in premature babies.

Area of Science:

  • Neonatology
  • Pediatric Nutrition
  • Bone Metabolism

Background:

  • Parenteral nutrition (PN) is essential for preterm infants, but its impact on bone development requires further investigation.
  • Identifying reliable markers for bone status in preterm neonates is critical for optimizing their long-term health.

Purpose of the Study:

  • To assess the effects of different parenteral nutrition regimens on growth and bone development in preterm infants.
  • To identify potential biomarkers for evaluating bone status in this vulnerable population.

Main Methods:

  • A study involving 234 preterm infants receiving two distinct nutritional regimens.
  • Metacarpus bone transmission time (mc-BTT) measurements at birth, 21 days, and 36 weeks of gestational age (GA).
  • Biochemical analyses and correlation of growth parameters with bone status markers.

Main Results:

  • Infants with aggressive nutrition showed improved growth rates and higher mc-BTT values.
  • Mc-BTT at 21 days correlated positively with nutritional intake and phosphatemia.
  • Low early energy intake and low serum phosphate levels at 21 days were associated with reduced mc-BTT at 36 weeks GA.

Conclusions:

  • Aggressive parenteral nutrition positively influences growth and bone status in preterm infants in the short to medium term.
  • Early nutritional interventions appear to play a significant role in bone development for preterm neonates.
Abstract

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
7.4K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
461
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
6.0K
Essential Minerals for Bone Health01:31

Essential Minerals for Bone Health

The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
7.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
702